Portside

Medicare is wasting hundreds of millions of dollars a year by failing to rein in doctors who routinely give patients pricey name-brand drugs when cheaper generic alternatives are available.

India's Intellectual Property Appellate Board allows license for generic cancer drug at fraction of cost of Bayer's.